P
69.30
-0.91 (-1.30%)
| 前收盘价格 | 70.21 |
| 收盘价格 | 69.59 |
| 成交量 | 288,178 |
| 平均成交量 (3个月) | 416,627 |
| 市值 | 3,332,222,208 |
| 市盈率 (P/E TTM) | 18.28 |
| 预期市盈率 (P/E Forward) | 14.51 |
| 价格/销量 (P/S) | 3.09 |
| 股市价格/股市净资产 (P/B) | 1.79 |
| 52周波幅 | |
| 利润日期 | 7 May 2026 |
| 营业毛利率 | 18.86% |
| 营业利益率 (TTM) | 34.03% |
| 稀释每股收益 (EPS TTM) | 4.29 |
| 季度收入增长率 (YOY) | 7.10% |
| 季度盈利增长率 (YOY) | 1.40% |
| 总债务/股东权益 (D/E MRQ) | 56.91% |
| 流动比率 (MRQ) | 4.20 |
| 营业现金流 (OCF TTM) | 251.52 M |
| 杠杆自由现金流 (LFCF TTM) | 188.69 M |
| 资产报酬率 (ROA TTM) | 6.50% |
| 股东权益报酬率 (ROE TTM) | 12.30% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 混合的 | |
| 股票 | Prestige Consumer Healthcare In | 看跌 | 看跌 |
AIStockmoo 评分
-1.0
| 分析师共识 | -3.5 |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.5 |
| 平均 | -1.00 |
|
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Core |
| 内部持股比例 | 1.23% |
| 机构持股比例 | 108.15% |
| 52周波幅 | ||
| 中 | 66.00 (-4.76%) | |
| 总计 | 1 保留 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Jefferies | 02 Feb 2026 | 66.00 (-4.76%) | 保留 | 65.44 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合